NEW YORK (GenomeWeb News) – The University of Texas Health Science Center at Houston will use nearly $30 million of the $49 million in funding it has received from the American Recovery and Reinvestment Act for genomics research related to cardiovascular and other diseases, according to UTHSC.

Included in the stimulus funding is $26 million for a study at the Human Genetics Centers at both The University of Texas School of Public Health and the Brown Foundation Institute of Molecular Medicine that will look for genetic factors associated with heart, lung, and blood diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.